Updated indications for the recombinant, adjuvanted RSV vaccine

2 minute read


Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×